Azitra, Inc. (NYSE:AZTR)
Azitra, Inc. is an early-stage clinical biopharmaceutical company, which engages in the development of therapeutic use in dermatology. The firm is involved in using engineered proteins and live bio therapeutic products that can be applied topically to treat diseases of the skin. It also offers a platform which is augmented by artificial intelligence and machine learning technology that analyzes, predicts, and helps screen library of strains for drug like molecules. The company was founded by Azim Munivar and Travis Whitfill on January 2, 2014 and is headquartered in Branford, CT.
21 Business Park Drive
Branford, Connecticut 06405
10
President, Chief Executive Officer & Director Francisco D Salva |
Chief Operating Officer & Director Travis Whitfill |
Independent Director Andrew Cain McClary MD |
Independent Director Barbara Ann Ryan |
Independent Director John R Schroer MBA |
Date | Form | Event |
---|---|---|
12 Aug, 2024 | 10-Q | |
12 Aug, 2024 | 8-K | |
2 Aug, 2024 | SC 13D/A | |
1 Aug, 2024 | SC 13G | |
29 Jul, 2024 | SC 13G | |
26 Jul, 2024 | 8-K | |
25 Jul, 2024 | 424B5 | |
23 Jul, 2024 | EFFECT | |
23 Jul, 2024 | CORRESP | |
23 Jul, 2024 | CORRESP | |
19 Jul, 2024 | S-1/A | |
15 Jul, 2024 | FWP | |
15 Jul, 2024 | S-1 | |
8 Jul, 2024 | EFFECT | |
5 Jul, 2024 | S-3/A | |
5 Jul, 2024 | CORRESP | |
3 Jul, 2024 | 8-K | |
2 Jul, 2024 | UPLOAD | |
1 Jul, 2024 | S-3 | |
18 Jun, 2024 | UPLOAD | |
14 Jun, 2024 | DRS | |
3 Jun, 2024 | DEF 14A | |
24 May, 2024 | PRE 14A | |
9 May, 2024 | 10-Q | |
9 May, 2024 | 8-K | |
29 Apr, 2024 | 10-K/A | |
1 Apr, 2024 | 4 | |
15 Mar, 2024 | 10-K | |
15 Mar, 2024 | 8-K | |
27 Feb, 2024 | SC 13G | |
26 Feb, 2024 | SC 13G/A | |
26 Feb, 2024 | SC 13G | |
15 Feb, 2024 | 4 | |
15 Feb, 2024 | 4 | |
15 Feb, 2024 | 4 | |
15 Feb, 2024 | 424B5 | |
14 Feb, 2024 | 8-K | |
13 Feb, 2024 | EFFECT | |
12 Feb, 2024 | SC 13G | |
9 Feb, 2024 | CORRESP | |
9 Feb, 2024 | CORRESP | |
11 Jan, 2024 | UPLOAD | |
4 Dec, 2023 | S-8 | |
14 Nov, 2023 | 10-Q | |
14 Nov, 2023 | 8-K | |
3 Oct, 2023 | 4 | |
3 Oct, 2023 | 4 | |
3 Oct, 2023 | 4 | |
3 Oct, 2023 | 4 | |
14 Aug, 2023 | 8-K | |
14 Aug, 2023 | 10-Q | |
24 Jul, 2023 | 3 | |
24 Jul, 2023 | 4 | |
11 Jul, 2023 | 8-K | |
7 Jul, 2023 | 8-K | |
3 Jul, 2023 | SC 13D | |
29 Jun, 2023 | 4/A | |
26 Jun, 2023 | 4 | |
23 Jun, 2023 | 4 | |
23 Jun, 2023 | 4 | |
23 Jun, 2023 | 4 | |
23 Jun, 2023 | 4 | |
21 Jun, 2023 | 8-K | |
21 Jun, 2023 | 424B4 | IPO completed |
15 Jun, 2023 | 3 | |
15 Jun, 2023 | EFFECT | |
15 Jun, 2023 | 3 | |
15 Jun, 2023 | 3 | |
15 Jun, 2023 | 3 | |
15 Jun, 2023 | 3 | |
15 Jun, 2023 | 3 | |
15 Jun, 2023 | 3 | |
15 Jun, 2023 | 3 | |
13 Jun, 2023 | CORRESP | |
13 Jun, 2023 | CORRESP | |
13 Jun, 2023 | CORRESP | |
13 Jun, 2023 | UPLOAD | |
13 Jun, 2023 | S-1/A | |
5 Jun, 2023 | FWP | |
5 Jun, 2023 | S-1/A | |
31 May, 2023 | CORRESP | |
30 May, 2023 | CORRESP | |
30 May, 2023 | CORRESP | |
26 May, 2023 | CORRESP | |
22 May, 2023 | CORRESP | |
22 May, 2023 | CORRESP | |
17 May, 2023 | CERT | |
17 May, 2023 | CORRESP | |
16 May, 2023 | S-1/A | |
16 May, 2023 | 8-A12B | |
15 May, 2023 | CORRESP | |
15 May, 2023 | CORRESP | |
9 May, 2023 | S-1/A | |
28 Apr, 2023 | FWP | |
11 Apr, 2023 | FWP | |
10 Apr, 2023 | S-1/A | |
10 Apr, 2023 | CORRESP | |
3 Apr, 2023 | UPLOAD | |
27 Mar, 2023 | FWP | |
20 Mar, 2023 | CORRESP | |
20 Mar, 2023 | S-1/A | |
10 Mar, 2023 | UPLOAD | |
21 Feb, 2023 | S-1 | |
21 Feb, 2023 | CORRESP | |
16 Jan, 2023 | UPLOAD | |
15 Dec, 2022 | DRS | |
12 Oct, 2022 | D | |
19 Jan, 2021 | D |
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.